ArticleNature cell biology2024
ECSIT facilitates memory CD8
Abstract read
In one paragraph
Article in Nature cell biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 13 citations in OpenAlex.
- Nicotinamide Metabolism Constrains Memory CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Humanized and Charge-Optimized CSPG4-Specific CAR-T Cells show Enhanced Efficacy against Head and Neck Squamous Cell Carcinoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Post-Translational Modifications in Cancer-Associated CD8⁺ T-Cell Exhaustion: Mechanisms and Therapeutic Opportunities.International journal of biological sciences · 2026Review
- Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression.Nature communications · 2025Article
- The epigenetic hallmarks of immune cells in cancer.Molecular cancer · 2025Review
- ECSIT-X4 is Required for Preventing Pressure Overload-Induced Cardiac Hypertrophy via Regulating Mitochondrial STAT3.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 5 institutions in 2 countries.
Yongbing Yang *Department of Immunology, State Key Laboratory of Reproductive Medicine, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Gusu School, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, National Vaccine Innovation Platform, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Yanan Wang *Department of Immunology, State Key Laboratory of Reproductive Medicine, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Gusu School, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, National Vaccine Innovation Platform, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0001-7481-4531
Zhongcheng WangSchool of Pharmacy, Nanjing Medical University, Nanjing, China.
Huanyu YanState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Yi GongDepartment of Immunology, State Key Laboratory of Reproductive Medicine, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Gusu School, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, National Vaccine Innovation Platform, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0002-0714-0407
Yingchao HuDepartment of Immunology, State Key Laboratory of Reproductive Medicine, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Gusu School, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, National Vaccine Innovation Platform, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
Yuying JiangDepartment of Immunology, State Key Laboratory of Reproductive Medicine, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Gusu School, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, National Vaccine Innovation Platform, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0002-3263-7730
Shuang WenDepartment of Immunology, State Key Laboratory of Reproductive Medicine, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Gusu School, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, National Vaccine Innovation Platform, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0002-5830-8038
Feifei XuSchool of Pharmacy, Nanjing Medical University, Nanjing, China.ORCID http://orcid.org/0000-0003-1978-5605
Bingwei WangDepartment of Pharmacology, Nanjing University of Chinese Medicine, Nanjing, China.ORCID http://orcid.org/0000-0002-9306-4323
Fiachra HumphriesDivision of Innate Immunity, Department of Medicine, UMass Chan Medical School, Worcester, MA, USA. Fiachra.Humphries@umassmed.edu.ORCID http://orcid.org/0000-0003-0216-5776
Yun ChenSchool of Pharmacy, Nanjing Medical University, Nanjing, China. ychen@njmu.edu.cn.ORCID http://orcid.org/0000-0002-0952-8851
Xi WangState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China. xiwang@njmu.edu.cn.ORCID http://orcid.org/0000-0002-7572-6354
Shuo YangDepartment of Immunology, State Key Laboratory of Reproductive Medicine, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Gusu School, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, National Vaccine Innovation Platform, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China. shuoyang01@njmu.edu.cn.ORCID http://orcid.org/0000-0003-4164-4438
Wuxi People's Hospital · CNNanjing Medical University · CNJiangnan University · CNNanjing University of Chinese Medicine · CNUMass Memorial Health Care · US
Funding
National Natural Science Foundation of China (National Science Foundation of China) 32170742National Natural Science Foundation of China (National Science Foundation of China) 32270921National Natural Science Foundation of China (National Science Foundation of China) 82070567National Natural Science Foundation of China (National Science Foundation of China) 82204354Natural Science Foundation of Jiangsu Province (Jiangsu Provincial Natural Science Foundation) BK20221352
Abstract
Memory CD8
Indexed as
CD8-Positive T-LymphocytesVirus DiseasesAdaptor Proteins, Signal TransducingCarcinogenesisCell Transformation, NeoplasticHumansPromoter Regions, GeneticAdaptor Proteins, Signal TransducingEcsit protein, human
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.